Drug Approval | April 11, 2023
Zydus receives final approval from the USFDA for Azithromycin Tablets
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation
To enable company to be future-ready by tapping potential in CDMO space
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Acetazolamide is used to treat glaucoma
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Subscribe To Our Newsletter & Stay Updated
